Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

How common is white coat hypertension?

Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH.

JAMA. 1988 Jan 8;259(2):225-8.

PMID:
3336140
2.

White coat hypertension diagnosed by 24-h ambulatory monitoring. Examination of 159 newly diagnosed hypertensive patients.

Høegholm A, Kristensen KS, Madsen NH, Svendsen TL.

Am J Hypertens. 1992 Feb;5(2):64-70.

PMID:
1550667
3.

Assessment of the white-coat effect.

Gerin W, Ogedegbe G, Schwartz JE, Chaplin WF, Goyal T, Clemow L, Davidson KW, Burg M, Lipsky S, Kentor R, Jhalani J, Shimbo D, Pickering TG.

J Hypertens. 2006 Jan;24(1):67-74.

PMID:
16331103
4.

[Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].

Amado P, Vasconcelos N, Santos I, Almeida L, Nazaré J, Carmona J.

Rev Port Cardiol. 1999 Oct;18(10):897-906. Portuguese.

PMID:
10590654
5.

Management of hypertension after ambulatory blood pressure monitoring.

Grin JM, McCabe EJ, White WB.

Ann Intern Med. 1993 Jun 1;118(11):833-7.

PMID:
8480956
6.

Difference between clinic and daytime blood pressure is not a measure of the white coat effect.

Parati G, Ulian L, Santucciu C, Omboni S, Mancia G.

Hypertension. 1998 May;31(5):1185-9.

7.

Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension.

Veglio F, Rabbia F, Riva P, Martini G, Genova GC, Milan A, Paglieri C, Carra R, Chiandussi L.

Clin Exp Hypertens. 2001 Apr;23(3):203-11.

PMID:
11339687
8.
9.

Prevalence and predictors of white-coat response in patients with treated hypertension.

MacDonald MB, Laing GP, Wilson MP, Wilson TW.

CMAJ. 1999 Aug 10;161(3):265-9.

10.

Nurse-measured or ambulatory blood pressure in routine hypertension care.

Veerman DP, van Montfrans GA.

J Hypertens. 1993 Mar;11(3):287-92.

PMID:
8387086
11.

Diagnosis of white coat hypertension by ambulatory blood pressure monitoring.

Owens P, Atkins N, O'Brien E.

Hypertension. 1999 Aug;34(2):267-72.

12.

Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white-coat' effect. Syst-Eur investigators.

Parati G, Omboni S, Staessen J, Thijs L, Fagard R, Ulian L, Mancia G.

J Hypertens. 1998 Jan;16(1):23-9.

PMID:
9533413
13.

Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring.

Staessen JA, Beilin L, Parati G, Waeber B, White W.

Blood Press Monit. 1999 Dec;4(6):319-31. Review.

PMID:
10602536
14.

Physiological, psychological, and behavioral factors and white coat hypertension.

Siegel WC, Blumenthal JA, Divine GW.

Hypertension. 1990 Aug;16(2):140-6.

15.

[White-coat hypertension].

Verdecchia P, Porcellati C.

G Ital Cardiol. 1995 Jul;25(7):899-909. Review. Italian.

PMID:
7557039
16.

Clinical implications of white coat hypertension: an ambulatory blood pressure monitoring study.

Manning G, Rushton L, Millar-Craig MW.

J Hum Hypertens. 1999 Dec;13(12):817-22.

PMID:
10618670
17.

The white-coat hypertension response: prevalence and predictors.

Lerman CE, Brody DS, Hui T, Lazaro C, Smith DG, Blum MJ.

J Gen Intern Med. 1989 May-Jun;4(3):226-31.

PMID:
2786060
18.

Blood Pressure Monitoring. Task force V: White-coat hypertension.

Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P.

Blood Press Monit. 1999 Dec;4(6):333-41. Review.

PMID:
10602537
19.
20.

Variability between current definitions of 'normal' ambulatory blood pressure. Implications in the assessment of white coat hypertension.

Verdecchia P, Schillaci G, Boldrini F, Zampi I, Porcellati C.

Hypertension. 1992 Oct;20(4):555-62.

Supplemental Content

Support Center